Investor Presentaiton

API Business Backward Integration - Strategic Importance Strategic Importance Customers Product Portfolio • Backward integration provides cost competitiveness and supply reliability • Large generic and innovator companies Approximately 300 APIS Pipeline Development Regulatory approvals Manufacturing Opiates Business Approx. 20 APIs scaled up annually . • 291 DMF/CEP approvals to date 396 DMF/CEP Filings to date • Across 14 facilities . Acquired GSK's Opiates business in Australia in Sept'15 © Sun Pharmaceutical Industries Limited. All Rights Reserved. SUN PHARMA 34

View entire presentation